Patient Engagement Advisory Committee; Notice of Meeting-Patient-Centered Informed Consent in Clinical Study

Resumen

The Food and Drug Administration (FDA or Agency) announces a forthcoming public advisory committee meeting of the Patient Engagement Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public.